2BTD:XETRA:XETRA-2BTD (USD)

COMMON STOCK | Others |

Last Closing

USD 32.196

Change

-0.41 (-1.27)%

Market Cap

N/A

Volume

26.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
USUP:XETRA UBS(Lux)Fund Solutions – MSC..

N/A

USD 1.07B
WEBH:XETRA Amundi MSCI USA UCITS ETF Acc ..

+0.24 (+0.62%)

USD 0.86B
CA1:XETRA Circus SE

-0.20 (-0.98%)

USD 0.51B
7V0:XETRA Darwin AG

+1.20 (+4.41%)

USD 0.08B
AXTZ:XETRA 21Shares Tezos staking ETP

+0.21 (+4.52%)

N/A
TY3S:XETRA WisdomTree US Treasuries 10Y 3..

N/A

N/A
42FB:XETRA AI/ML Innovations Inc.

+0.01 (+21.95%)

N/A
8PSC:XETRA Source Physical Palladium P

-1.48 (-1.63%)

N/A
BTIC:XETRA Invesco Physical Bitcoin ETN E..

+1.76 (+1.99%)

N/A
BRNK:XETRA BRANICKS Group AG

-0.08 (-3.41%)

N/A

ETFs Containing 2BTD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.94% 50% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.94% 50% F 37% F
Trailing 12 Months  
Capital Gain 80.75% 78% C+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 80.75% 78% C+ 94% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 55.28% 83% B 97% N/A
Dividend Return 55.28% 83% B 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.10% 33% F 13% F
Risk Adjusted Return 84.91% 83% B 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.